COMMUNIQUÉS West-GlobeNewswire

Predictive Biotech Signs Letter of Intent With IQVIA to Begin Clincial Trial for Osteoarthritis of the Knee
14/05/2019
Company shifts focus of human cell and tissue products to biopharmaceuticals SALT LAKE CITY, May 14, 2019 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data analytics for [...]
Shineco, Inc. Enters into Strategic Cooperation Agreement with Heilongjiang Provincial Science Research Institute of Healthy Food to Establish NewHemp Food Processing Laboratory
14/05/2019
BEIJING, May 14, 2019 (GLOBE NEWSWIRE) -- Shineco, Inc. ("Shineco" or the "Company"; NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural produce, specialized textiles, and various [...]
Homology Medicines Announces FDA Fast Track Designation for HMI-102 Gene Therapy Development Candidate for Adults with PKU
14/05/2019
- Company Provides Details of pheNIX, the First Gene Therapy Trial for PKU, and Remains on Track to Report Initial Clinical Results from the Phase 1/2 Study in 2019 - BEDFORD, Mass., May 14, 2019 (GLOBE NEWSWIRE) -- [...]
Driven Deliveries, Inc. Enters $530 Million Nevada Cannabis Market
14/05/2019
SAN DIEGO, May 14, 2019 (GLOBE NEWSWIRE) -- Driven Deliveries, Inc., (OTC: DRVD), the world’s first publicly traded cannabis delivery company, announced today that it has successfully launched operations in Nevada with [...]
Transactions in relation to share buyback program
14/05/2019
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 1, 2019, in accordance with article 5 of Regulation (EU) no. 596/2014 of April 16, 2014 on [...]
CV Sciences’ PlusCBD Oil™ Used in First Study Examining Clinical Benefit of CBD for Patients with PTSD
14/05/2019
Study Finds CBD Associated with PTSD Symptom Reduction in Adults with PTSD LAS VEGAS, May 14, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent [...]
CareDx applauds HHS Report on Cost Savings of Lifetime Immunosuppressive Drug Coverage for Transplant Patients
14/05/2019
Extending Medicare coverage of medication saves $73M BRISBANE, Calif., May 14, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading molecular diagnostics company focused on the discovery, development, and [...]
Sun BioPharma, Inc. Provides a Business Update and Files Report for Q1 2019
14/05/2019
Enrollment in Second Cohort of PDA Combination Study Completed New Funding Totaling $0.8 Million Secured MINNEAPOLIS, May 14, 2019 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (OTCQB:SNBP), a clinical stage biopharmaceutical [...]
Progenics Pharmaceuticals and ROTOP Pharmaka GmbH Announce European Collaboration for Prostate Cancer Imaging Agent 1404
14/05/2019
Leading Radiopharmaceutical Company ROTOP to Develop and Commercialize Progenics’ PSMA-Targeted SPECT/CT Imaging Agent in Europe NEW YORK & DRESDEN, Germany, May 14, 2019 (GLOBE NEWSWIRE) -- Progenics [...]
Protech Home Medical Announces Date and Time for Quarterly Conference Call
14/05/2019
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. CINCINNATI, May 14, 2019 (GLOBE NEWSWIRE) -- Protech Home [...]
Alimera Sciences to Present at the 20th Annual B. Riley FBR Institutional Investor Conference on May 22, 2019
14/05/2019
ATLANTA, May 14, 2019 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a leader in the commercialization and development of prescription ophthalmic pharmaceuticals, announces that President and CEO, [...]
Amunix Expands Executive Team with Appointment of Dr. Mika Derynck as CMO, Dr. Darcy Mootz as CBO, and Yvonne Li as SVP of Finance
14/05/2019
MOUNTAIN VIEW, Calif., May 14, 2019 (GLOBE NEWSWIRE) -- Amunix Pharmaceuticals, Inc. (“Amunix”), a biopharmaceutical company focused on the discovery and development of novel protein therapeutics, continues to build [...]
Yamo Pharmaceuticals Presents Results from Phase 2 Study of L1-79 in Adolescents and Young Adult Males with Autism Spectrum Disorder at INSAR 2019
14/05/2019
New York , May 14, 2019 (GLOBE NEWSWIRE) -- Yamo Pharmaceuticals, LLC , a clinical stage pharmaceutical company developing a novel therapy for autism spectrum disorder (ASD), announced the presentation of results from a [...]
resTORbio Appoints Lloyd Klickstein, M.D., Ph.D., as Chief Scientific Officer
14/05/2019
BOSTON, May 14, 2019 (GLOBE NEWSWIRE) -- resTORbio, Inc. (Nasdaq: TORC), a clinical-stage biopharmaceutical company developing innovative medicines that target the biology of aging to prevent or treat aging-related [...]
Medexus Pharmaceuticals Announces Normal Course Issuer Bid
14/05/2019
MONTREAL, Quebec, May 14, 2019 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company”) (TSXV: MDP, OTCQB: PDDPF) announced today it has submitted to the TSX Venture Exchange (the “ Exchange ”) a notice of its [...]
CinCor Pharma In-Licenses Aldosterone Synthase Inhibitor, CIN-107, and Closes $50 Million Series A Financing
14/05/2019
Financing led by Sofinnova Investments to advance CIN-107 through clinical proof-of-concept in two indications CINCINNATI, May 14, 2019 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (“CinCor”) announced today that it has [...]
Uptick Newswire Hosts Marijuana Company of America, Inc. on The Stock Day Podcast to Discuss Its Expansion in the Cannabis Industry
14/05/2019
PHOENIX, May 14, 2019 (GLOBE NEWSWIRE) -- Uptick Newswire Stock Day Podcast welcomed Marijuana Company of America, Inc. (MCOA)(“the Company”), a Company that specializes in the development of hemp-based products, as [...]
LogicBio Reports First Quarter 2019 Financial Results and Provides Business Updates
14/05/2019
CAMBRIDGE, Mass., May 14, 2019 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (Nasdaq:LOGC) (LogicBio or the Company), a genome editing company focused on developing medicines to durably treat rare diseases, today [...]
Abeona Therapeutics Treats First Patient in Second Cohort of Phase 1/2 Clinical Trial for ABO-101 in Sanfilippo Syndrome Type B (MPS IIIB)
14/05/2019
Interim data expected in the second half of 2019 NEW YORK and CLEVELAND, May 14, 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced that [...]

Pages